Sanofi-Aventis
Registered Principal Details
Business Or Interest:
Pharmaceutical Manufacturing
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Anne Whitaker
Vice President
Pharmaceutical Manufacturing
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Anne Whitaker
Vice President
Contact
JD
Joseph Devaney
55 Corporate Drive, Mail Stop 5A-500A P.O. Box 5925
Bridgewater, NJ 08807
(908) 981-4988
(908) 203-7307
joseph.devaney@sanofi.com
http://www.sanofi.us
55 Corporate Drive, Mail Stop 5A-500A P.O. Box 5925
Bridgewater, NJ 08807
(908) 981-4988
(908) 203-7307
joseph.devaney@sanofi.com
http://www.sanofi.us
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|---|---|---|
Russell Sobotta | Exclusive Duties N/A | Authorized On 12/21/2012 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 292
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
Bill Text and History
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
Bill Text and History
Other
Notification Date1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
2/6/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
For
Notification Date2/6/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 502
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
Bill Text and History
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
Bill Text and History
Other
Notification Date1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 251
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
Bill Text and History
2013 Wisconsin Act 294
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
Bill Text and History
2013 Wisconsin Act 294
Other
Notification Date1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 375
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
Bill Text and History
2013 Wisconsin Act 239
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
Bill Text and History
2013 Wisconsin Act 239
Other
Notification Date1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs -- Administration
Health Services: Medical Assistance and Related Programs -- Administration
Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Pharmaceuticals/Biotechnology research and development
Pharmaceuticals/Biotechnology research and development
Action Intended To Affect
Both Legislative matter and rule
Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Research and development tax credits
Research and development tax credits
Action Intended To Affect
Both Legislative matter and rule
Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2013 January - June $19,183.43 |
2013 July - December $24,026.08 |
2014 January - June $21,865.74 |
2014 July - December $0.00 |
Total $65,075.24 |
Total Hours Communicating | 2013 January - June 17.00 |
2013 July - December 20.00 |
2014 January - June 35.00 |
2014 July - December 0.00 |
Total 72.00 |
Total Hours Other | 2013 January - June 11.50 |
2013 July - December 11.50 |
2014 January - June 20.00 |
2014 July - December 0.00 |
Total 43.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June |
2013 July - December 25% |
2014 January - June 5% |
2014 July - December |
Total 10% |
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June |
2013 July - December 25% |
2014 January - June 5% |
2014 July - December |
Total 10% |
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June |
2013 July - December |
2014 January - June 10% |
2014 July - December |
Total 5% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June |
2013 July - December |
2014 January - June 10% |
2014 July - December |
Total 5% |
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June |
2013 July - December |
2014 January - June 15% |
2014 July - December |
Total 7% |
Budget Bill Subjects
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June 20% |
2013 July - December |
2014 January - June 30% |
2014 July - December |
Total 20% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June 10% |
2013 July - December |
2014 January - June |
2014 July - December |
Total 2% |
2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
---|---|---|---|---|
2013 January - June 10% |
2013 July - December |
2014 January - June 5% |
2014 July - December |
Total 5% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication